Here are the answers to some of the most common questions regarding West Nile Virus. All the information has been provided by the Center for Disease Control.

Q. What is West Nile Virus?
A. West Nile Virus is a flavivirus commonly found in Africa, West Asia, and the Middle East. It is closely related to St. Louis encephalitis virus which is also found in the United States. The virus can infect humans, birds, mosquitoes, horses and some other mammals

Q. What are West Nile encephalitis, West Nile meningitis and “neuroinvasive disease”?
A. The most severe type of disease due to a person being infected with West Nile virus is sometimes called “neuroinvasive disease” because it affects a person’s nervous system. Specific types of neuroinvasive disease include: West Nile encephalitis, West Nile meningitis or West Nile meningoencephalitis. Encephalitis refers to an inflammation of the brain, meningitis is an inflammation of the membrane around the brain and the spinal cord, and meningoencephalitis refers to inflammation of the brain and the membrane surrounding it.


Q. What are the symptoms of West Nile Virus (WNV) encephalitis?
A. The symptoms include headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. It is estimated that approximately 1 in 150 persons infected with the West Nile virus will develop a more severe form of disease. Serious illness can occur in people of any age, however people over age 50 and some immunocompromised persons (for example, transplant patients) are at the highest risk for getting severely ill when infected with WNV.

Q. What is the incubation period in humans (i.e., time from infection to onset of disease symptoms) for West Nile disease?

A. Usually 2 to 15 days.

Q. How long do symptoms last?
A. The symptoms of encephalitis or meningitis may last several weeks, although neurological effects may be permanent.

Q. How is West Nile encephalitis treated?

A. There is no specific treatment for West Nile virus infection. In more severe cases, intensive supportive therapy is indicated, often involving hospitalization, intravenous fluids, airway management, respiratory support (ventilator), prevention of secondary infections (pneumonia, urinary tract, etc.), and good nursing care.

For more information, please visit these sites:
The US Center for Disease Control and Prevention